Online citations, reference lists, and bibliographies.
← Back to Search

Application Of Ulex Europaeus Agglutinin I-modified Liposomes For Oral Vaccine: Ex Vivo Bioadhesion And In Vivo Immunity.

Kexin Li, X. Zhao, Shiyi Xu, DaHai Pang, Chunrong Yang, D. Chen
Published 2011 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
The conjugation of Ulex europaeus agglutinin I (UEAI) onto surface of liposomes has been demonstrated to effectively improve the intestinal absorption of antigen, subsequently induced strong mucosal and systemic immune responses. In this context, we prepared bovine serum albumin (BSA)-encapsulating UEAI-modified liposomes (UEAI-LIP) and unmodified ones (LIP). The specific bioadhesion on mice gastro-intestinal mucosa was studied ex vivo. An important increase of interaction between UEAI-conjugated liposomes and the intestinal segments with Peyer's Patches (PPs) was observed compared with the unconjugated one (p<0.01). However, under the presence of α-L-fucose, which is the reported specific sugar for UEAI, specifically inhibited the activity of these conjugates. The immune-stimulating activity in vivo was studied by measuring immunoglobulin G (IgG) levels in serum and immunoglobulin A (IgA) levels in intestinal mucosal secretions following oral administration of BSA solution, LIP and UEAI-LIP in mice. Results indicate that antigen encapsulated in liposomes, especially the UEAI-modified ones, was favorable for inducing immune response. At 42 d after the first immunization, the highest IgG and IgA antibody levels produced by UEAI-LIP occurred, respectively showing 4.4-fold and 5-fold higher levels compared to those of the groups receiving BSA alone. This data demonstrated high potential of UEAI-modified liposomes for their use as carrier for oral vaccines.
This paper references
Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity.
Seiichiro Minato (2003)
Application of the Higuchi model for drug release from dispersed matrices to particles of general shape
M. Brophy (1987)
Binding and Uptake of Wheat Germ Agglutinin-Grafted PLGA-Nanospheres by Caco-2 Monolayers
A. Weissenboeck (2004)
Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses.
P. Rajananthanan (1999)
Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus.
I. Ezpeleta (1999)
Ovalbumin encapsulation into liposomes results in distinct degrees of oral immunization in mice.
A. Alves (2008)
Lectins and microparticles for enhanced oral vaccination.
E. Lavelle (2006)
Immunological Implications of the use of Plant Lectins for Drug and Vaccine Targeting to the Gastrointestinal Tract
E. Lavelle (2004)
Lectin-mediated drug targeting: history and applications.
C. Bies (2004)
Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome-entrapped antigen.
Takuya Irie (2003)
Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
D. Mishra (2008)
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
Prolonged Immune Response Evoked by a Single Subcutaneous Injection of Microcapsules Having a Monophasic Antigen Release
H. Sah (1996)
In vitro evaluation of biodegradable microspheres with surface-bound ligands.
Mark E. Keegan (2006)
Targetability of novel immunoliposomes prepared by a new antibody conjugation technique.
G. Bendas (1999)
Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome.
L. Xing (2003)
The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery.
F. Gabor (2004)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar